Market Context — Why This Technology, Why Now

The medical device industry faces increasing pressure for personalized medicine and improved patient outcomes, alongside rising healthcare costs. This technology aligns perfectly by offering customized, high-performance implants that could reduce long-term care expenses and surgical complications. Regulatory bodies are also favoring innovations that enhance safety and efficacy, creating a strong market pull for such advanced biomaterials.

Key Competitive Advantages
01

Integrates Dense and Porous Structures: Combines high mechanical strength with superior bio-integration properties.

02

Delivers High Porous Strength: Achieves high mechanical strength in porous regions using a ceramic-chelate reaction product, surpassing conventional porous materials.

03

Secures Strong IP: Overcame rigorous examination citing 12 prior art documents, establishing unique patentability in a competitive domain.

Market Opportunity
Artificial Bone and Implants
$10B globally (AI est.)
Aging populations and rising lifestyle diseases are increasing the number of patients with bone disorders, driving demand for high-performance artificial bones and implants.
Orthopedic device manufacturers Medical implant specialists Biomaterial suppliers
Dental Implants
$4B globally (AI est.)
A growing number of patients prioritize masticatory function recovery in addition to aesthetics. This creates demand for implants with superior biocompatibility and durability.
Dental implant manufacturers Oral and maxillofacial surgery device companies Dental material developers
Regenerative Medicine and Tissue Engineering
$2B globally (AI est.)
There is increasing demand for materials with controlled structure and properties, such as cell culture scaffolds, to promote the regeneration of living tissues.
Tissue engineering companies Cell culture media and scaffold providers Biotech firms developing organoids
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a 3D formed object featuring both dense and porous sections, along with its manufacturing method and control program. It successfully navigated rigorous examination, citing 12 prior art documents, demonstrating strong validity and a robust scope of protection against invalidation.

Competitive White Space

The patent focuses on ceramic-chelate reaction products for 3D bioprinted structures. White space could include novel bio-inks for soft tissue engineering, advanced sensor integration within implants, or non-ceramic composite materials for similar applications.

Economic Impact
~$1.5M–$3.5M/year estimated healthcare cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Applying this technology to artificial bone replacement surgeries could reduce re-operation rates from a conventional 5% to 1%. For 1,000 surgeries annually, with re-operation costs at ~$35K/case (AI est.), reducing 4 re-operations per year would directly save ~$150K (AI est.) in costs. Including benefits from accelerated patient recovery and improved quality of life, the total economic impact could reach several million dollars annually.

Speed to Market
4× faster than in-house development
Developing similar technology in-house would require at least 4 years for R&D, covering material selection, 3D printing process establishment, biocompatibility evaluation, and strength testing. This technology, with its foundational research completed and patented by RIKEN, could allow licensees to shorten time-to-market to approximately 1 year. Established knowledge in material composition and density control optimizes development resources for implementation.
Competitive Positioning

X: Biocompatibility & Functionality
Y: Customization & Manufacturing Efficiency

Business Models & Applications
📝 Product Licensing
A model for licensing the development, manufacturing, and sales of artificial bone and dental implant products based on this technology to medical device manufacturers.
🤝 Joint Research and Development
A model for integrating a partner company's manufacturing technology with this technology through joint R&D focused on specific applications or materials.
📦 Material and Intermediate Supply
A model for supplying ceramic materials or dense/porous intermediate structures, developed using this technology, to final product manufacturers.
Adjacent Application Opportunities
🏥 Medical Devices
Customized Artificial Joint Development
3D print artificial joints with dense and porous structures tailored to individual patient skeletal needs. This could enhance biocompatibility, potentially shortening post-operative recovery times by 20% and improving durability.
🦷 Dental Care
Next-Generation Dental Implants
Offer dental implants integrating porous sections for strong jawbone fusion and dense sections for superior durability. This could contribute to long-term stability and enhanced patient comfort, potentially extending implant lifespan by 1.5x.
🚀 Aerospace & Automotive
Lightweight High-Strength Structural Components
Apply to structural components in aircraft and automobiles requiring both lightweighting and high strength in specific areas. Integrated molding of complex internal structures could improve performance by 15-20% and reduce manufacturing costs.
Integration Roadmap — Estimated 24-Month Deployment
Phase 1: Fundamental Verification & Design Optimization
Duration: 6 months
Adjust the technology's material composition and 3D printing parameters to meet the licensee's specific product requirements. Verify compatibility with existing 3D printers and establish optimal printing profiles.
Phase 2: Prototyping & Biocompatibility Evaluation
Duration: 12 months
Manufacture prototypes based on optimized designs. Conduct mechanical strength tests according to ISO standards and perform in vitro/in vivo biocompatibility evaluations to confirm product safety.
Phase 3: Mass Production & Regulatory Approval Application
Duration: 6 months
Establish a mass production system based on prototyping and evaluation results, and prepare for medical device regulatory approval applications. This could enable early market entry and commercialization.
Technical Feasibility
This technology involves 3D formed objects using ceramic materials and chelating agents, with claims covering the manufacturing method and control program. This suggests relatively easy integration into existing ceramic 3D printing technologies and material compounding processes by applying this technology's control algorithms and material formulations. It is estimated that technical hurdles are low, as implementation could involve software updates and material composition adjustments without major modifications to existing equipment.
Success Scenario
Adopting this technology could enable licensees to manufacture customized artificial bones and implants tailored to individual patient needs. This could improve surgical success rates and is expected to shorten patient post-operative recovery periods by an average of 20%. Consequently, a scenario of enhanced healthcare facility operational efficiency and significantly improved patient satisfaction is envisioned. Ultimately, this could establish a competitive advantage in the market and build new high-value product lines.
Patent Record
APPLICATION NO.
JP2020-169561
REGISTRATION NO.
7595337
FILING DATE
2020/10/07
GRANT DATE
2024/11/28
EXPIRATION DATE
2040/10/07
PATENT HOLDER
国立研究開発法人理化学研究所
Examination History
2023-03-29
Amendment (Voluntary)
2023-09-07
Request for Examination
2024-08-30
Office Action
2024-10-22
Amendment (Voluntary)
2024-10-22
Applicant's Response
2024-11-05
Decision to Grant